Literature DB >> 17479932

Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals.

Andrea Holmes1, Mairín McMenamin, Fiona Mulcahy, Colm Bergin.   

Abstract

Hypertrophic genital herpes is a disfiguring manifestation of a common infection seen in immunocompromised hosts that can be clinically mistaken for malignancy. We review the literature and describe hypertrophic genital herpes in a human immunodeficiency virus-positive patient receiving antiretroviral therapy. Treatment with valacyclovir, cidofovir, and foscarnet failed, but thalidomide treatment was successful.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479932     DOI: 10.1086/517513

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Vulvar pseudotumoral acyclovir-resistant herpes in an HIV-negative, non-immunosuppressed patient: A therapeutic challenge.

Authors:  Jun Hu; John C Krauss; Micheline Moyal-Barracco; Laraine L Washer; Hope K Haefner; Ebony Parker-Featherstone
Journal:  Int J Womens Dermatol       Date:  2021-06-20

2.  Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females.

Authors:  Dhs Tan
Journal:  Int J Womens Health       Date:  2012-07-19

3.  Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.

Authors:  Mark H Yudin; Rupert Kaul
Journal:  Infect Dis Obstet Gynecol       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.